142 related articles for article (PubMed ID: 7541997)
1. Maternal serum levels of alpha-fetoprotein and fetal fibronectin as markers of labor in the third trimester.
Khandelwal M; Lynch L; Lockwood CJ; Ainbender E
Am J Perinatol; 1995 May; 12(3):161-3. PubMed ID: 7541997
[TBL] [Abstract][Full Text] [Related]
2. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
Williams MA; Hickok DE; Zingheim RW; Mittendorf R; Kimelman J; Mahony BS
Obstet Gynecol; 1992 Nov; 80(5):745-9. PubMed ID: 1383900
[TBL] [Abstract][Full Text] [Related]
3. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
[TBL] [Abstract][Full Text] [Related]
5. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
[TBL] [Abstract][Full Text] [Related]
6. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
[TBL] [Abstract][Full Text] [Related]
7. The association between second-trimester maternal serum alpha-fetoprotein in 14-22 weeks and adverse pregnancy outcome.
Dehghani-Firouzabadi R; Tayebi N; Ghasemi N; Tahmasbi Z
Acta Med Iran; 2010; 48(4):234-8. PubMed ID: 21279936
[TBL] [Abstract][Full Text] [Related]
8. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
9. Maternal and fetal serum transformed alpha-fetoprotein levels in normal pregnancy.
González-Bugatto F; Foncubierta E; Bailén Mde L; Illanes S; Hervías-Vivancos B; Bartha JL
J Obstet Gynaecol Res; 2009 Apr; 35(2):271-6. PubMed ID: 19453690
[TBL] [Abstract][Full Text] [Related]
10. Transformed alpha-fetoprotein (t-AFP) levels in women with threatened preterm labor.
González-Bugatto F; Bailén Mde L; Fernández-Macías R; Fernández-Deudero A; Hervías-Vivancos B; Bartha JL
Gynecol Obstet Invest; 2009; 68(3):199-204. PubMed ID: 19672090
[TBL] [Abstract][Full Text] [Related]
11. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption.
Tikkanen M; Hämäläinen E; Nuutila M; Paavonen J; Ylikorkala O; Hiilesmaa V
Prenat Diagn; 2007 Mar; 27(3):240-3. PubMed ID: 17238224
[TBL] [Abstract][Full Text] [Related]
12. Unexplained elevated maternal serum alpha-fetoprotein levels and pregnancy outcome in twins.
Hong S; Berkowitz G; Wang W; Stone J; Ainbender E
Obstet Gynecol; 1996 Sep; 88(3):337-42. PubMed ID: 8752235
[TBL] [Abstract][Full Text] [Related]
13. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
Maher JE; Davis RO; Goldenberg RL; Boots LR; DuBard MB
Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
[TBL] [Abstract][Full Text] [Related]
14. Alpha-fetoprotein in women during pregnancy and in the neonate during intrapartum.
Chen RJ; Lin YH; Wang CW; Huang SC; Chow SN
Am J Perinatol; 1994 Jul; 11(4):279-81. PubMed ID: 7524512
[TBL] [Abstract][Full Text] [Related]
15. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
[TBL] [Abstract][Full Text] [Related]
16. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
[TBL] [Abstract][Full Text] [Related]
17. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
18. [Economical impact of preterm delivery management based on fetal fibronectin results].
García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
[TBL] [Abstract][Full Text] [Related]
19. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
20. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein.
Burton BK
Obstet Gynecol; 1988 Nov; 72(5):709-13. PubMed ID: 2459638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
